Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

609 public trials 216 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Completed

TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers

NCT03829436

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +58 more
Locations
  • University of California - San Francisco San Francisco, California, United States
  • Miami Cancer Institute Miami, Florida, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
View Trial Details
Completed

An Open-Label, Multicenter, Phase 1/2 Study of Poly(ADP-Ribose) Polymerase (PARP) Inhibitor E7449 as Single Agent in Subjects With Advanced Solid Tumors or With B-cell Malignancies and in Combination With Temozolomide (TMZ) or With Carboplatin and Paclitaxel in Subjects With Advanced Solid Tumors

NCT01618136

Conditions
Adnexal Diseases, Advanced Melanoma, B-cell Malignancy, Low-grade, +37 more
Locations
  • King's College London Guy's Hospital Campus London, United Kingdom
  • Newcastle Upon Tyne NHS Foundation Trust Newcastle Upon Tyne and Wear, United Kingdom
View Trial Details
Completed

A Study of KN046 in Subjects With Locally Advanced or Metastatic Triple-negative Breast Cancer

NCT03872791

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
View Trial Details
Completed

Study Of Single-dose Cyclophosphamide +Pembrolizumab In Patients With Metastatic Triple Negative Breast Cancer

NCT02768701

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • George Washington University-Medical Faculty Associates Washington D.C., District of Columbia, United States
  • Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
  • Cone Health Cancer Center Greensboro, North Carolina, United States
  • Rex Cancer Center Raleigh, North Carolina, United States
View Trial Details
Completed

A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

NCT03849469

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced or Metastatic Solid Tumors, +108 more
Locations
  • UCSD Medical Center - Encinitas Encinitas, California, United States
  • Koman Family Outpatient Pavilion La Jolla, California, United States
  • UC San Diego Medical Center - La Jolla (Jacobs Medical Center / Thornton Pavilion) La Jolla, California, United States
  • UCSD Altman Clinical and Translational Research Institute Building (ACTRI) La Jolla, California, United States
View all 28 locations
View Trial Details
Completed

A Study of EDP1503 in Patients With Colorectal Cancer, Breast Cancer, and Checkpoint Inhibitor Relapsed Tumors

NCT03775850

Conditions
Adenocarcinoma, Bladder Cancer, Breast Diseases, +35 more
Locations
  • Highlands Oncology Group Rogers, Arkansas, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Stephenson Cancer Center Oklahoma City, Oklahoma, United States
  • Tennessee Oncology, PLLC Chattanooga, Tennessee, United States
View Trial Details
Completed

A Study of the Safety, Efficacy, and Pharmacokinetics of Tiragolumab in Combination With Atezolizumab and Chemotherapy in Participants With Triple-Negative Breast Cancer

NCT04584112

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Univ of Chicago Chicago, Illinois, United States
  • Levine Cancer Institute Charlotte, North Carolina, United States
  • Magee-Woman's Hospital Pittsburgh, Pennsylvania, United States
View all 24 locations
View Trial Details
Completed

A Dose Escalation and Cohort Expansion Study of NKTR-214 in Combination With Nivolumab and Other Anti-Cancer Therapies in Patients With Select Advanced Solid Tumors

NCT02983045

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +55 more
Locations
  • UCSD, Moores Cancer Center La Jolla, California, United States
  • UCLA Los Angeles, California, United States
  • Stanford Cancer Institute Stanford, California, United States
  • University of Colorado, Denver Denver, Colorado, United States
View all 58 locations
View Trial Details
Completed

A Safety Study of SGN-LIV1A in Breast Cancer Patients

NCT01969643

Conditions
Breast Diseases, Breast Neoplasms, HER2 Mutations Breast Neoplasms, +11 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Pinnacle Oncology Hematology Scottsdale, Arizona, United States
  • UC San Diego / Moores Cancer Center La Jolla, California, United States
  • Cedars Sinai Medical Center / Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
View all 38 locations
View Trial Details

Related conditions